Clinical Trials Directory

Trials / Unknown

UnknownNCT05443958

The Role of Intracranial Electroencephalography (IEEG) in the Localization of Epileptogenic Zones (EZ) and Its Relationship With Prognosis

The Role of IEEG in the Localization of EZ and Its Relationship With Prognosis

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
3 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The mechanism of epilepsy pathogenesis is complex and not fully defined, and about 20-30% of patients with seizures that cannot be completely controlled by drugs become drug-resistant epilepsy. For focal drug-resistant epilepsy, surgical removal of the epileptogenic zone can control seizures, but the overall seizure-free rate in the long term after surgery is 60-70%, and the results are still not satisfactory. Accurate assessment of the location and extent of the epileptogenic zone and its adequate excision are prerequisites for the success or failure of surgery. Intracranial EEG (iEEG) has been shown to be the most accurate method for determining the location and boundaries of the epileptogenic zone. It can selectively record the local cortical electrical activity through intracranial electrodes and achieve high temporal resolution for long-range recording, reliably reflecting the continuous dynamic changes of EEG during interictal and ictal periods. The in-depth analysis of iEEG can improve the efficacy of epilepsy surgery and provide important information to reveal the pathogenesis of epilepsy.

Conditions

Interventions

TypeNameDescription
OTHER

Timeline

Start date
2022-07-01
Primary completion
2023-12-30
Completion
2025-12-30
First posted
2022-07-05
Last updated
2022-07-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05443958. Inclusion in this directory is not an endorsement.